Five things for pharma marketers to know: Wednesday, May 2, 2018

J&J's Janssen to buy BeneVir; Regulators approve new use of Kymriah; Deaths from synthetic opioids surpass prescription opioids.

from Most popular articles from Medical Marketing and Media https://ift.tt/2HJECxS